CSR
2021
December
“Wei Ai Xu Hang” Liver Cancer Patients Support Project
To gain liver cancer patients more effective and timely treatment, reduce their families’ financial costs, and lengthen the patients’ lives, the China Primary Health Care Foundation started the “Wei Ai Xu Hang” Liver Cancer Patients Support Project in Jan 2019. Eisai China provided the medicine Lenvatinib (Lenvima®) for the foundation. The project is aim at helping patients who need Lenvatinib to cure liver cancer to gain a longer and more effective treatment. By the end of December 2021, the project has supported over 26,816 liver cancer patients and Eisai China has donated Lenvatinib over 337,006 boxes in total, which is valued at over 4.5 billion yuan.
December
Party-building Excellent Alliance Unit
November
2018-2022 Suzhou Civilization Unit
August
No. 88 in China’s Top 100 Pharmaceutical Industry Companies in 2020
July
Contribution Award For Health Development in County